BACKGROUND: The FINE-CKD model was developed to estimate the cost-effectiveness of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). OBJECTIVE: To perform internal ...
As the industry moves toward continuous bioprocessing, more effective ways are being developed to validate viral clearance. Researchers at Asahi Kasei Bioprocess America have developed a small-scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results